Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Porcelli

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
British Journal of Cancer|November 17, 2004
Laminin-5 offsets the efficacy of gefitinib ('Iressa') in hepatocellular carcinoma cellsG Giannelli, A Azzariti, E Fransvea, et al.
Current Medicinal Chemistry|September 3, 2013
New vascular disrupting agents in upper gastrointestinal malignanciesA E Quatrale, L Porcelli, A Gnoni, et al.
Ciba Foundation Symposium|January 1, 1979
Human leucocyte elastase and cathepsin G: structural and functional characteristicsJ Travis, P J Giles, L Porcelli, et al.
Current Medicinal Chemistry|July 14, 2012
Synthetic lethality to overcome cancer drug resistanceL Porcelli, A E Quatrale, P Mantuano, et al.
Current Pharmaceutical Design|September 15, 2012
Synergistic antiproliferative and antiangiogenic effects of EGFR and mTOR inhibitorsL Porcelli, A E Quatrale, P Mantuano, et al.
Cancer Letters|December 25, 2018
Synthesis and biological evaluation of N-biphenyl-nicotinic based moiety compounds: A new class of antimitotic agents for the treatment of Hodgkin LymphomaL Porcelli, D Stolfa, A Stefanachi, et al.
International Journal of Molecular Medicine|May 29, 2008
Validation of gefitinib effectiveness in a broad panel of head and neck squamous carcinoma cellsS Sebastian, A Azzariti, R Accardi, et al.
Cell Death & Disease|February 22, 2014
Expression of base excision repair key factors and miR17 in familial and sporadic breast cancerS De Summa, R Pinto, B Pilato, et al.
British Journal of Cancer|February 10, 2011
Aurora B kinase inhibitor AZD1152: determinants of action and ability to enhance chemotherapeutics effectiveness in pancreatic and colon cancerA Azzariti, G Bocci, L Porcelli, et al.
Journal of Medicinal Chemistry|November 16, 2011
Synthesis, characterization and biological evaluation of ureidofibrate-like derivatives endowed with peroxisome proliferator-activated receptor activityL Porcelli, F Gilardi, A Laghezza, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
British Journal of Cancer|November 17, 2004
Laminin-5 offsets the efficacy of gefitinib ('Iressa') in hepatocellular carcinoma cellsG Giannelli, A Azzariti, E Fransvea, et al.
Current Medicinal Chemistry|September 3, 2013
New vascular disrupting agents in upper gastrointestinal malignanciesA E Quatrale, L Porcelli, A Gnoni, et al.
Ciba Foundation Symposium|January 1, 1979
Human leucocyte elastase and cathepsin G: structural and functional characteristicsJ Travis, P J Giles, L Porcelli, et al.
Current Medicinal Chemistry|July 14, 2012
Synthetic lethality to overcome cancer drug resistanceL Porcelli, A E Quatrale, P Mantuano, et al.
Current Pharmaceutical Design|September 15, 2012
Synergistic antiproliferative and antiangiogenic effects of EGFR and mTOR inhibitorsL Porcelli, A E Quatrale, P Mantuano, et al.
Cancer Letters|December 25, 2018
Synthesis and biological evaluation of N-biphenyl-nicotinic based moiety compounds: A new class of antimitotic agents for the treatment of Hodgkin LymphomaL Porcelli, D Stolfa, A Stefanachi, et al.
International Journal of Molecular Medicine|May 29, 2008
Validation of gefitinib effectiveness in a broad panel of head and neck squamous carcinoma cellsS Sebastian, A Azzariti, R Accardi, et al.
Cell Death & Disease|February 22, 2014
Expression of base excision repair key factors and miR17 in familial and sporadic breast cancerS De Summa, R Pinto, B Pilato, et al.
British Journal of Cancer|February 10, 2011
Aurora B kinase inhibitor AZD1152: determinants of action and ability to enhance chemotherapeutics effectiveness in pancreatic and colon cancerA Azzariti, G Bocci, L Porcelli, et al.
Journal of Medicinal Chemistry|November 16, 2011
Synthesis, characterization and biological evaluation of ureidofibrate-like derivatives endowed with peroxisome proliferator-activated receptor activityL Porcelli, F Gilardi, A Laghezza, et al.
Pageof 1